期刊文献+

老年慢性阻塞性肺疾病患者238例病原菌特点分析

Analysis on characteristics of pathogenic bacteria in 238 elderly patients with COPD
暂未订购
导出
摘要 目的了解老年慢性阻塞性肺疾病(COPD)患者痰菌状况及耐药情况。方法对238例老年科住院的COPD患者痰菌分离培养,药敏试验采用M IC法。结果革兰阴性菌487株(500株)占97.4%,其中不动杆菌属、铜绿假单胞菌、肺炎克雷伯菌为主要病种。药敏结果表明细菌耐药性为增强,但亚胺培南、环丙沙星、哌拉西林/他唑巴坦、阿米卡星大多数细菌敏感。结论结论COPD患者的致病菌仍以革兰阴性菌为主,不动杆菌属、铜绿假单胞菌、肺炎克雷伯菌为主要病种,细菌耐药性明显增强。了解病原菌分布特点及耐药性监测指导临床合理使用抗生素。 Objective To observe characteristics of pathogenic bacteria in the elderly patients with COPD. Methods In 238 elderly patients with COPD, Isolation and culture of sputum was done, and drug sensitive test was performed with MIC. Results In 500 pathogenic bacteria, there were 487gram-negative bacteria ( 97.4% ), included acinetobacter, pseudomonas aeruginosa and kebsiella pneumoniae. The drug sensitive test showed that bacterial drug resistance strenghtened, but bacteria were sensitive to imipenem,ciprofloxacin and amikacin. Conclusion The main pathogenic bacteria in patients with COPD is gram-negaative bacteria,which will be helpful to administrate antibiotics rationally in clinic.
作者 陈家杰
出处 《临床合理用药杂志》 2009年第12期21-22,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 慢性阻塞性肺疾病 致病菌 药敏试验 老年性 COPD, Pathogenic bacteria Drug sensitive test The elderly
  • 相关文献

参考文献5

二级参考文献17

  • 1Towner KJ. Clinical importance and antibiotic resistance of Acinetobacter spp.J Med Microbiol, 1997,46 : 721 - 746.
  • 2Bergogne-Berezin E,Towner KJ. Acinetobacter spp. as nosocomial pathogens:microbiological, clinical, and epidemiological features. Clin Microbiol Rev,1996,9:148 - 165.
  • 3Paul CS, Alexander VG.Acinetobacter, Achromobacter, Alcaligenes,Moraxella, Methylobacterium, and OtherNonfermentative GramNegative Rods. P R.Murray, E J.Baron, M A.Pfaller, et al. Mannal ofclinical microbiology,7th edition.539~543.
  • 4Valero C,Garcia Palomo JD, Matorras P, et al. Acinetobater bacteraemia in ateaching hospital,1989-1998. Eux J Intem Med,2001; 12:425~429.
  • 5The cost of antibiotic resistance: effect of resistance among Staphylococcusaureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudmonas aeruginosa onlength of hospital stay.Infect Control Hosp Epidemiol,2002;Feb;23:106~108.
  • 6National Committee for Clinical Laboratory Standards 2001.Performance standards forantimicrobial susceptibility testing. l lth information supplment. NCCLS document M100-S11 National Committee for Clinical Laboratory Standards, Wayne, Pa.
  • 7Srifuengfung S, Sangsawang M, Komolpis P, et al. Bacterial pathogens(non-Mycobacterium) from sputum culture and antimicrobial susceptibility. Southeast AsianJ Trop Med Public Health, 1998 ;29:96~99.
  • 8Chen MZ, Hsueh PR, Lee LN, et al. Severe Community-Acquired Pneumonia due toAcinetobacter baumannii. Chest, 2001; 120:1072~1077.
  • 9Koeleman JG, Van der Bijl MW, Stoof J, et al. Antibiotic resistance is a major riskfactor for epidemic behavior of Acinetobacter baumannii. Infect control HospEpidemiol,2001 ;22:284~288.
  • 10Roberts SA, Findlay R, Lang SD. estigation of an outbreak of multidrug resistanceAcinetobacter baumannii in an intensive care burn units.J Hosp Infect,2001 ;48:228~232.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部